ARROWHEAD PHARMACEUTICALS, INC. Insider Trading for January 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARROWHEAD PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ARROWHEAD PHARMACEUTICALS, INC. for January 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 24 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 13.15 | 17,500 | 230,125 | 898,856 | 916.4 K to 898.9 K (-1.91 %) |
| Jan 24 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 13.59 | 152,000 | 2,065,680 | 916,356 | 1.1 M to 916.4 K (-14.23 %) |
| Jan 24 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Sell | S | 13.58 | 3,000 | 40,740 | 178,130 | 181.1 K to 178.1 K (-1.66 %) |
| Jan 18 2019 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Sell | S | 14.43 | 72,000 | 1,038,960 | 233,000 | 305 K to 233 K (-23.61 %) |
| Jan 18 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 14.55 | 81,875 | 1,191,281 | 305,607 | 387.5 K to 305.6 K (-21.13 %) |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | Li Zhen | Snr. VP, Chem and N ... | Sell | S | 14.34 | 40,500 | 580,770 | 201,700 | 242.2 K to 201.7 K (-16.72 %) |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 6.20 | 1,000 | 6,200 | 543,334 | |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Option Exercise | M | 2.62 | 11,666 | 30,565 | 544,334 | |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 14.40 | 42,666 | 614,390 | 1,068,356 | 1.1 M to 1.1 M (-3.84 %) |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 6.20 | 1,000 | 6,200 | 1,111,022 | 1.1 M to 1.1 M (+0.09 %) |
| Jan 16 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Buy | M | 2.62 | 11,666 | 30,565 | 1,110,022 | 1.1 M to 1.1 M (+1.06 %) |
| Jan 11 2019 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Sell | S | 14.77 | 8,500 | 125,545 | 46,500 | 55 K to 46.5 K (-15.45 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Waddill William D. | Director | Grant | A | 0.00 | 30,000 | 0 | 55,000 | 25 K to 55 K (+120.00 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Ferrari Mauro | Director | Grant | A | 0.00 | 3,429 | 0 | 19,656 | 16.2 K to 19.7 K (+21.13 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | PERRY MICHAEL S | Director | Grant | A | 0.00 | 36,000 | 0 | 221,000 | 185 K to 221 K (+19.46 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN DOUGLAS B | Director | Grant | A | 0.00 | 36,000 | 0 | 181,130 | 145.1 K to 181.1 K (+24.81 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Li Zhen | Snr. VP, Chem and N ... | Grant | A | 0.00 | 75,000 | 0 | 242,200 | 167.2 K to 242.2 K (+44.86 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | O'Brien Patrick | General Counsel | Grant | A | 0.00 | 70,000 | 0 | 305,000 | 235 K to 305 K (+29.79 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Sell | S | 11.98 | 8,333 | 99,829 | 387,482 | 395.8 K to 387.5 K (-2.11 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Myszkowski Kenneth Allen | Chief Financial Off ... | Grant | A | 0.00 | 85,000 | 0 | 395,815 | 310.8 K to 395.8 K (+27.35 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Sell | S | 11.98 | 20,000 | 239,600 | 1,098,356 | 1.1 M to 1.1 M (-1.79 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | GIVEN BRUCE D | Chief Operating Off ... | Grant | A | 0.00 | 210,000 | 0 | 1,118,356 | 908.4 K to 1.1 M (+23.12 %) |
| Jan 03 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Grant | A | 0.00 | 600,000 | 0 | 2,142,455 | 1.5 M to 2.1 M (+38.90 %) |